The differentiation and management of inflammatory bowel disease

Anna Mokrowiecka; Ewa Małecka-Panas

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

1/2007
vol. 10

Send email

Copy url:

abstract:

The differentiation and management of inflammatory bowel disease

Anna Mokrowiecka

,

Ewa Małecka-Panas

Przew Lek 2007; 1: 56-65

Online publish date: 2007/03/05

View full text Get citation

Despite the progress in our knowledge of inflammatory bowel disease immunology and genetic pathways, there is still a lack of a single gold standard and diagnosis is based on clinical, radiographic and endoscopic methods with histopathological assessment. Even when combining all available conventional diagnostic methods the exact diagnosis still remains inconclusive and these cases are classified as indeterminate colitis. Several serologic methods are under evaluation due to their diagnostic usefulness. The newest therapies targeting various levels of immunologic processes have been recently developed, particularly those connected with tumour necrosis factor alpha.

keywords:

The differentiation and management of inflammatory bowel disease

Anna Mokrowiecka , Ewa Małecka-Panas

ulcerative colitis, Crohn’s disease, indeterminate colitis, inflammatory bowel disease, diagnosis, drug therapy

Anna Mokrowiecka

,

Ewa Małecka-Panas